Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
[PubMed] Goldstein AL, Kleinman HK
N., and Singh, S
Table 3: Percent (%) of Type 1 Diabetes Patients Experiencing at Least One Episode of Severe Hypoglycemia or Hypoglycemia on TRESIBA in Open Label Adult and Pediatric Clinical Trials Table 4: Percent (%) of Patients with Type 2 Diabetes Experiencing at Least One Episode of Severe Hypoglycemia or Hypoglycemia on TRESIBA in Open Label Adult Clinical Trials Hypersensitivity Reactions Severe, life threatening, generalized allergy, including anaphylaxis, generalized skin reactions, angioedema, bronchospasm, hypotension, and shock have occurred with insulin, including TRESIBA and may be life threatening
***Its energising so AVOID use at night time, and do NOT exceed 5g daily*** There are no reviews yet
Vollenweider et al., 2010)
